PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, initiated expansion Nov. 12 of its clinical site at Rockford, IL.
The site is one of two U.S.-based PCI locations supporting investigational medicinal products, complementing facilities in the U.K., Europe and Australia.
The facility expansion at the Rockford location will provide 30,000 sq ft of additional space in support of primary and secondary packaging and labeling operations for investigational medicinal products at the Clinical Services Center of Excellence, including a dedicated 2°-8°C packaging suite for Cold Chain products.
PCI features highly specialized capability and expertise in supporting temperature-sensitive therapies, including cold chain and ultra cold chain, at temperatures ranging from controlled room temperature (CRT) 15°-25°C, 2°-8°C, down to -20°C, -30°, -40°C, -80°C, and including cryogenic storage below -196°C for advanced therapeutic medicinal products, including cell and gene therapies, as well as customized refrigerated and frozen temperatures according to client needs.
The expanded building, which is expected to open for business in late 2019 following internal fit-out and a period of validation and licensing, will provide increased flexibility to meet customer needs. Purpose-built for scalable primary and secondary packaging and labeling, the new packaging suites offer maximum flexibility, with the ability to operate on either a stand-alone or integrated basis across suites.
